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Introduction
Treatment of heart failure with new generation devices in combination with more adequate preoperative indications [1] [2] [3] and postoperative treatments allows patients to be supported for longer time. Although this trend may partially compensate the ongoing lack of organs available for heart transplantation, longer support times expose patients to a higher rate of long-term complications such as infections. In this context diagnosis and extent of the infection to internal ventricular assist device (VAD)-components can play a crucial role in therapeutic management. Moreover, early recognition of left ventricular assist device (LVAD) infection may potentially result in a more appropriate treatment with a consequent attenuation of its deleterious effects. Recent publications have reported several advantages of 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography ( 18 F-FDG PET/CT) in detecting infection of prosthetic valve or cardiovascular implantable electronic devices. 4, 5 In this setting, we adopted the same concept to patients on VAD since July 2009 and we hereby report our extensive experience with PET/CT in a reasonable number of patients.
Patients and methods
This is a single-centre study including 61 Table 1 . Three patients underwent VAD implantation elsewhere and have been referred to our centre for evaluation of transplantation.
Clinical data were prospectively collected in two informatics systems. The University of Münster Ethical Committee and Institutional Review Board approved the study, and patient consent was waived. PET/CT was performed once in 38 patients while 9 patients underwent repeated examinations (a total of 23 examinations). In details one patient underwent 4, three patients 3 and five patients 2 PET/CT examinations, respectively.
In 24 cases PET/CT was performed although there were no external signs of infection; however, there were clinical signs of infection including recurrence of bacteraemia (in absence of another identifiable source) and/or elevated infectious parameters with fever of unknown origin. The other 29 cases were suspicious for local signs of infection (along the sternotomy scar or at the driveline exit site). In these cases the examination was performed with the aim of confirming the local infection and to determine the extent of infection to the internal VAD components. Finally six patients without signs of infection underwent eight PET/CT examinations. Main indications for PET/CT in these patients were tumour staging and exclusion of a tumour prior to transplantation listing. In details one patient had a bronchial carcinoma ( Table 2 , patient no. 33) and received a total of 3 PET/CT in order to stage the tumour and plan the radiotherapy. Another patient ( Table 2 reports in details all indications. Regarding the indication to PET/CT the attending surgeon and cardiologist responsible of LVAD program were involved in all cases. Final diagnosis (standard of reference) of LVAD specific infection was prospectively performed based upon microbiological samples taken at hospital admission, during the surgical revision/transplantation and recurrence of symptoms on long-term follow-up. Infection was defined according to the adverse event definition of the Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS). This includes a positive culture from the skin and/or tissue surrounding the drive line or from the tissue surrounding the external housing of a pump implanted within the body unless strong clinical evidence despite negative cultures, coupled with the need to treat with antimicrobial therapy, when there is clinical evidence of infection such as pain, fever, drainage, or leukocytosis. 6 Positron-emission tomography/ computed tomography findings have only been regarded as additional/ contributive information and were never the sole determinant for the final patient management decision. Consequently, diagnostic procedures following PET/CT assisted the physicians to confirm or dismiss the clinical relevance of PET/CT findings.
Patient preparation and PET/CT examination
Details concerning the 18 F-FDG PET/CT procedures have been published elsewhere. 7, 8 To optimally suppress glucose uptake in the myocardium, all patients were studied after fasting for at least 6 h. In details the lowest interval was 8 h and the median fasting hour was 12 h (IQR 4 h). Blood glucose levels at the time of . Low-dose CT of the entire area covered by PET (from skull base to the mid-thigh level) was performed for attenuation correction and anatomical correlation in all patients. After completion of the CT scan, PET data were acquired for 3 min per bed position. Positron-emission tomography images were reconstructed using the standard manufacturer-supplied software.
PET image analysis and statistical analysis
All PET/CT scans were reviewed and analysed by two readers, experienced in PET analysis, who were not aware of clinical signs and symptoms, or of the final diagnosis. Image analysis was performed using the Siemens Syngo.via software (Version 2). F-FDG uptake was evaluated both, qualitatively and quantitatively at the driveline skin penetration point (level 1) and along the driveline subcutaneously (level 2) in the attenuation-corrected PET images, as well as qualitatively and semi-quantitatively around the LVAD aggregate (level 3) in the uncorrected PET images. Analysis of attenuation corrected images at this level was intentionally not performed due to strong attenuation artefacts predominately present in the area. In fact metallic implants generate artefacts on CT images because of their high photon absorption. 9 which lead to an overestimation of tracer concentration in that region and thereby could result in a false-positive PET finding. Qualitative analysis of uncorrected PET images was performed by a visual grading system using a 4-point scoring system (0: none 1: slightly elevated but lower then lung uptake, 2: moderate uptake, but less or equal as liver uptake, 4: uptake levels higher then liver uptake). Thereafter, visual scores were compared with the report of the nuclear medicine physician at the time of the exam. For quantitative analysis SUV max and SUV mean were considered. A semi-quantitative analysis of the uncorrected PET series was performed using target-to-background ratios (TBR) between absolute maximum counts in the VOI around the LVAD aggregate and absolute mean counts in a VOI in the right deltoid muscle and the right lung lobe with no signs of pathological processes. Data are presented as median (IQR) for continuous variables and categorical variables are expressed as frequencies. Comparisons of PET assessments for each level between patients with and without VAD infection were performed using the Mann-Whitney U-test. A receiver operating characteristic (ROC) curve was calculated from the SUV max regarding the first level (driveline) and for the semi-quantitative TBR regarding the third level (pump housing). This allowed assessing the cut-off values with the combination of the best sensitivity and specificity to detect infection (presence = 1; absence of infection = 0). Statistical significance was assumed at a value of P < 0.05. Data analysis was performed using SPSS for Windows (Version 23/SPSS Inc., Chicago, IL, USA) and Excel 2010 (Microsoft, Redmond, WA, USA).
Final diagnosis and management
After a median time interval of 4.36 months (lower quartile = 2.89, upper quartile = 8.75) between PET/CT and last follow-up in July 2016 a total of 40 (65.6%) LVAD infections were ascertained. Cultures and procedures that lead to the final diagnosis of infection included as follows: blood cultures were positive in 13 cases, isolated positive swabs cultures at the exit site of driveline in 12, in 13 cases there were a positive blood culture and swabs. In two patients despite recurrence of symptoms microbiological cultures remained negative. A total of 29, 37 and 13 of superficial, deep driveline and pump housing infections could be ascertained at last follow-up. A total of 19 patients underwent urgent heart transplantation whereas 15 patients were still alive on VAD at last follow-up, of them 31 surgical driveline revisions were necessary in 5 patients. One patient underwent LVAD removal due to heart recovery and 12 patients died while on VAD.
PET findings
Abnormal tracer uptake suggestive of infection of the LVAD components was found in 42 (68.85%) examinations. Matching with the final diagnosis there were 36 true positive, 15 true negative, 4 false negative, and 6 false positive findings resulting in an overall sensitivity, specificity, and positive and negative predictive value of 90.0, 71.4, 85.7, and 78.9%, respectively. Figures 1-3 show two true positive and one true negative findings, respectively. Four patients with normal PET/CT findings had a F-FDG uptake could be detected along the outflow graft (Dacron graft) of VAD connected to the aorta which was classified as a non-VAD infection. This patient was successfully treated with antibiotics and any relapse could be recorded. In another patient (patient no. 21) during the transplantation occurred 44 days after the PET/CT a pericardial sterile fluid collection could be observed as signs of past LVAD infection. In this case, the long antibiotic treatment could explain the false negative findings. Another patient (patient no. 5) with positive blood cultures without other possible focus of infection died from an intracranial haemorrhage. In this case we cannot exclude the possible infection of inner surface of LVAD that generated septic emboli. Hence in this case the false negative can be due to the bad performance of PET/CT in the diagnosis of pump housing infection. In the last patient (patient no. 25), the presence a chronic fistula could have been the cause for the low performance of the PET. Six patients with an abnormal 18 F-FDG uptake of VAD components did not have any VAD-Infection (false positive). Interestingly, one of them (patient no. 1), despite a positive PET/CT finding and no signs of LVAD infection (negative swabs und negative blood cultures), underwent a second PET/CT examination 1 month later that confirmed clinical signs of infection (positive blood culture). One patient (patient no. 33) who underwent PET/CT for evaluation for transplantation and one for tumour staging had a positive PET/CT finding at the driveline skin penetration point, however all microbiological samples remained negative. Eleven cases among the 57 examinations performed for suspected LVAD infection showed non-VAD-related findings suspicious for infection including the following localizations: lung (five cases), intestines (five cases), spinal cord (one case), and cardiovascular implantable electronic device infections (two cases). Ten patients (patient nos. 4, 6, 7, 8, 12, 12,   19 , 23, 29, and 32) underwent PET/CT within 3 months after the LVAD implantation. Five patients were true positive and five true negative. Neither false positive nor negative findings were reported. Four of five patients with a true positive finding underwent heart transplantation after a median of 1.74 month (lower quartile = 0.75, upper quartile = 3.77). During the transplantation in three patients pus collection could be detected around the pump housing. In another patient, surgical samples revealed Staphylococcus aureus. Another patient underwent surgical revision and VAC treatment of the driveline. In three of the true negative patients PET/CT detected another focus responsible for the infection, including pneumonia in one and leg abscess in two patients.
Level sub-analysis
A total number of 29 superficial and 35 deep driveline infections could be recorded at the last follow-up. Regarding the superficial infection (first level) sub-analysis of SUV max showed an optimal discriminator power (AUC of level 1-0.824 95% CI 0.706-0.910, P < 0.001). A SUV max cut-off value of > _5.95 led to 62.1% sensitivity and 90.6% specificity (Figure 4) . Patients with a superficial driveline infection had a median SUV max at the driveline skin penetration point of 6.62 compared with patients without superficial driveline infection, median SUV max 2.15 (P < 0.001). Qualitative analysis indicated a median visual score of 3 (lower quartile = 2, upper quartile = 3) for patients with percutaneous infection vs. 0.5 (lower quartile = 0, upper quartile = 2) in patients without (P < 0.001). Regarding the second level sub-analyses of SUV max confirmed an optimal discriminator power for levels (AUC of level 2-0.849, CI 0.734-0.928, P < 0.001). A SUV max cut-off value of 3.93 led to 80.0% sensitivity and 76.9% specificity ( Figure 5 ). Patients with a deep driveline infection had a median SUV max of 8.83 vs. 2.97 Figure 4 Receiver-operating characteristic curve of maximum standardized uptake value (SUV max) for the diagnosis of superficial driveline infection. At the third level (pump housing) semi-quantitative analysis showed poor discriminator power (AUC 0.589, 95% CI 0.456-0.713, P = 0.33). Patients with a pump housing infection had a TBR to lung parenchyma of 2.26 vs. 1.43 in patients with and without (P = 0.144) and a TBR to deltoid muscle of 2.80 vs. 2.07 (P = 0.32) (Figures 6 and  7) , respectively. Moreover qualitative analysis indicated a median visual score of 3 (lower quartile = 0, upper quartile = 3) for patients with pump infection vs. 0 (lower quartile = 0, upper quartile = 3) in patients without pump infection (P = 0.07). All PET/CT assessments and the different comparisons between patients with and without VAD infection according to the different levels are presented in Table 3 .
Patients without signs of infection (eight PET/CT examinations) had the following values: the median SUV max at piercing site of driveline was 2.18 (2.54 IQR) and along the intracorporeal course of the driveline 3.23 (IQR 1.8), respectively. For the pump housing the TBR to deltoid muscle was 1.65 (IQR 0.98) and the TBR to lung parenchyma was 1.05 (IQR 1.47).
Discussion
The current study is the first report in literature dealing with a reasonable number of 18 F-FDG PET/CT examinations performed in patients supported with a CF-LVAD. The main finding emerging from it is the high diagnostic power of PET/CT in detecting driveline infections. The hereby reported sensitivity and specificity for VAD infection were 90%, 71.4% with a positive and negative predictive value of 85.7 and 78.9%, respectively. Moreover, PET/CT not only enables the physician to detect driveline infection, but can also reveal other non-VAD-related infection foci. All these findings represented a solid basis for a potentially better treatment of our patients.
In the near future, due to the organ shortage for heart transplantation and due to longer life expectancy with consecutively agerelated heart disease, physicians involved in the treatment of heart failure will face an exponential growing number of patients on LVAD. This growth will likely be exacerbated by better survival rates due to new devices, improved preoperative indications for VAD implantation and the postoperative management. As consequence we will face a growing number of patients with LVAD presenting long-term complications such as infection. In this setting, several groups have already shown the deleterious effects of infection in patients on VAD.
To date, John et al. 10 reported among a cohort of 332 patients supported with a HVAD a driveline infection rate of 0.25 events per patient-year. Statistical analysis showed no negative impact on survival in patients with driveline exit-site infections, however there was a trend toward reduced survival in patients with sepsis events when compared to those without. Dealing with a larger cohort (2006 CF-LVAD recipients), Goldstein et al. 11 found after a mean follow-up of 8.1 months significantly (P < 0.01) better survival in patients without percutaneous driveline infection. Gordon et al. 12 showed in a prospective, multicentre study (11 US cardiac centres, 150 patients) in patients supported with Heartmate that VAD infection significantly increases 1-year mortality (HR = 5.6; P < 0.0001). Koval et al. 13 found after median period of 232 days (longer than the abovementioned studies) an increased risk for death in patients with driveline infection while on VAD support (HR 2.20, P = 0.01). In this context it is out of debate that early diagnosis of infection can provide the basis for a prompt management of these patients potentially resulting in an attenuation of the deleterious effects of infection. Literature has already shown that there have been attempts to detect infection through 18 F-FDG PET/CT. To date, Tlili et al.
14 reported a case of a 59-year-old female patient with a Haertmate II device who underwent PET/CT because the suspect of assuming deep driveline infection. In the same line, Fujino et al. 15 reported a case of 41-year-old man with Dura Heart who underwent PET/CT because of LVAD infection. Kim et al. 16 reported a series of five (four VAD infections, one control) patients who underwent PET/CT after LVAD implantation. In this series PET/CT clearly showed the high diagnostic power in detecting driveline infection. In our larger cohort we confirm these findings emphasizing the diagnostic power of PET/CT. A total number of 29 superficial and 37 deep driveline infections could be recorded at the last follow-up. Sub-analyses of SUV max showed an optimal discriminator power for superficial and deep infection. Qualitative analysis showed highly significant differences between patients with and without driveline infection (P < 0.001). Despite the optimal discriminator power for both superficial and deep infections there were still some performance differences. The sensitivity of PET/CT for diagnosis of superficial infection was lower comparing with the sensibility regarding the diagnosis of deep driveline infections (62.1 vs. 80.0%). A possible explanation could reside in the local treatment of superficial infections attenuating the signs of infection in PET/CT. In contrast with this finding, the higher sensitivity in diagnosis of deep driveline infection can translate from a clinical point of view into a better understanding of infection extend, potentially enhancing improving the treatment of all foci. However, the high diagnostic power of PET/CT in detecting driveline infection could not be confirmed for pump housing infections. However qualitative visual analysis indicated a trend towards significance (P = 0.07). This limitation is most probably caused by unspecific 18 F-FDG uptake due to foreign body reaction around the LVAD on the one hand and physiological tracer uptake into adjacent left ventricular myocardium on the other hand. In our study particular techniques for the suppression of myocardial glucose metabolism such as preparation with low carb diets or administration of heparin were not performed routinely. In further prospective studies dealing with the topic of 18 F FDG PET/CT imaging of VAD infections this should optionally be considered. Along with this limitation other possible ones that could have generated the false negative findings might lay in the use of antibiotics prior to PET/CT, the presence of chronic fistula and possible infection of the inner surface of pump housing. The latter can ultimately cause thromboembolic events miming the presence of an endocarditis. At this level (pump housing) despite the non-attenuation corrected imaging the diagnostic power of PET/CT regarding infection of the inner surface of the device remains very limited. Another finding emerging from the present study concerns the timing of PET/CT. Ten patients underwent PET/CT within 3 months after the LVAD implantation. Surprisingly, neither false positive nor negative findings were reported. The high sensitivity could be explained by the high grade of infection that justified the urgent transplantation in these single cases. In fact during the transplantation in three patients pus collection could be observed around the pump housing. Normally, unspecific 18 F FDG uptake due to postimplantation changes and post-surgical wound healing is expected in the first weeks to months after surgery so that particularly specificity is limited and false positive results may be observed. In this context, regarding the observed high specificity we believe that only more numerous observations can help draw more solid conclusions and generate better insights. Thus, we advocate caution when interpreting these results obtained early after LVAD implantation.
Further limitations include the retrospective design of study with its disadvantages by nature. PET/CT assessment was not corrected in accordance to the EANM Research Ltd (EARL) criteria. Furthermore a dual time point imaging was not performed and its diagnostic validity must be explored in further prospective evaluations. Moreover 
